Luckwel Pharmaceuticals Inc. announced earnings results for the third quarter ended December 31, 2019. For the third quarter, the company announced net loss was USD 134,045 compared to USD 262,810 a year ago. Basic loss per share from continuing operations was USD 0.001 compared to USD 0.002 a year ago. For the nine months, net loss was USD 385,946 compared to USD 642,262 a year ago. Basic loss per share from continuing operations was USD 0.003 compared to USD 0.005 a year ago.